Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/26/19
End: 02/17/22
Due: 02/17/23
Phase: N/A
Priority: Normal
Start: 12/08/15
End: 11/13/17
Due: 11/13/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor | NCT03985072 | Andes Biotechnologies | user2@example.com | None | 2019-04-26 | 2022-02-17 | 2023-02-17 | - | - | 2025-07-14 |
| Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors | NCT02508441 | Andes Biotechnologies | user2@example.com | None | 2015-12-08 | 2017-11-13 | 2018-11-13 | - | - | 2025-07-14 |